The short versionNo company is legally allowed to sell retatrutide to consumers. Lilly: "Anyone purporting to sell retatrutide to consumers is breaking the law."[9]
What the retatrutide peptide is
Retatrutide is a single synthetic peptide with a fatty-acid chain attached, developed by Eli Lilly as a once-weekly injection.[2] In its request to the FDA, Lilly described the molecule as 41 amino acids in total: a backbone of 39 alpha amino acids plus a two-residue side chain.[3] The only retatrutide tested in published trials was made by Lilly and given under medical supervision.[2]
"Retatrutide peptides" sold online are products that claim to contain this molecule. Nobody outside the seller checks that claim. The FDA has not approved any of them, and Lilly has not licensed anyone else to make or sell the drug.[9][1] In November 2026 Lilly repeated that retatrutide "is an investigational molecule that cannot be legally sold or marketed for human use."[10]
What "research use only" means
The FDA says it has seen products labeled "for research purposes" or "not for human consumption" being "sold directly to consumers for human use with dosing instructions."[1] A label does not change what a product is. If it is marketed for people to inject, the FDA treats it as an unapproved drug.
The FDA also states that "retatrutide and cagrilintide cannot be used in compounding under federal law."[1] That rules out compounding pharmacies as a legal source too.
Is compounded retatrutide legal?
No. The FDA says retatrutide "cannot be used in compounding under federal law", so a compounding pharmacy cannot legally make it.[1] The FDA has sent a warning letter to a compounder over retatrutide, and in August 2026 Lilly sued compounding pharmacies among other sellers.[5][11] Retatrutide is also not legal to sell to consumers in any other form, because it is not approved anywhere.[9]
Peptide retatrutide vs the drug used in trials
| Lilly's retatrutide in trials | Peptide sold online as retatrutide | |
|---|---|---|
| Who made it | Eli Lilly, for registered studies | Unknown manufacturer |
| Checked by a regulator | Studied under FDA-regulated trial rules | No |
| Identity and dose verified | Yes, as part of the trial | Seller's claim only |
| Sterility | Made for injection in humans | Unknown |
| Medical monitoring | Screening, dose escalation and follow-up visits | None |
| Legal to sell to consumers | Not sold to consumers | No |
That gap is why trial results, like those on the results page, say nothing about what is inside an online vial.
What regulators and Lilly have done
Action against sellers has grown since 2024. The FDA has sent warning letters naming retatrutide since December 2024, including letters in March and August 2026 to online peptide sellers that used "research use only" labels.[4][6][7] The August 2026 letter noted that a seller offered bacteriostatic water together with a "peptide guide" and a "peptide calculator", which the FDA took as evidence the products were meant for people.[7] This site does not sell or link to any product, and its calculators are general arithmetic.
- Import controls. In September 2025 the FDA launched a "green list" import alert to stop unapproved GLP-1 ingredients at the border.[8]
- Lawsuits. On August 12, 2026 Lilly announced six lawsuits against compounding pharmacies, medical spas and online sellers, and said it had referred more than 200 individuals and entities to authorities.[11]
The full list of cases and letters is on Eli Lilly retatrutide lawsuits and FDA enforcement.
The risks of peptides sold as retatrutide
- Unknown contents. No regulator checks what is in the vial, how much, or whether it is sterile.
- No medical oversight. Trial participants were screened and monitored. People buying online are not.
- Reported harms. A 2026 JAMA Network Open study collected adverse events reported by social-media users taking nonapproved retatrutide.[12]
- Known side effects still apply. Even the real drug caused nausea in about 4 in 10 people on 12 mg in trials. See retatrutide side effects.
The legal routes instead
The only legal ways to receive retatrutide are a clinical trial or a physician-requested expanded-access program. ClinicalTrials.gov lists both.[13] Details: how to get retatrutide and FDA approval status.
Frequently asked questions
Is it legal to buy retatrutide peptide online?
Can a compounding pharmacy make retatrutide?
No. The FDA says retatrutide cannot be used in compounding under federal law.[1]
Are retatrutide peptides the same as Lilly's retatrutide?
Who is suing retatrutide peptide sellers?
Eli Lilly. In August 2026 it announced six lawsuits against U.S. compounding pharmacies, medical spas and online sellers.[11] See the lawsuits page.
Sources
- FDA's concerns with unapproved GLP-1 drugs used for weight loss
- Jastreboff AM et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial
- Eli Lilly and Company v. Kennedy, No. 1:24-cv-01503-TWP-KMB, order on cross-motions for summary judgment
- Warning letter: Summit Research Peptides
- Warning letter: GLP-1 Solution
- Warning letter: Gram Peptides
- Warning letter: Royal Peptides LLC
- FDA launches "green list" to protect Americans from illegal imported GLP-1 drug ingredients
- Lilly: retatrutide vs semaglutide 2 mg in TRANSCEND-T2D-2
- Lilly to showcase new retatrutide, Taltz (ixekizumab) and Zepbound (tirzepatide) data at ACR Convergence 2026
- Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market
- Sehgal NKR et al. Self-reported adverse events with nonapproved retatrutide
- Retatrutide studies (NCT04881760, NCT05929066, NCT05931367, NCT06662383, NCT07629401 and others)